Purchases and Sales Made in Q2 2025 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q2 2025. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2025
Q2 2025
|
Morgan Stanley
New York, NY |
BUY
|
- |
1.5M+ 1277.72% |
$1.41M - $2.13M
|
1.61M
$4.29M
|
|
|
Aug 14, 2025
Q2 2025
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
20.6KNew |
$19.3K - $29.2K
|
20.6K
$54.7K
|
|
|
Aug 12, 2025
Q2 2025
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
16K+ 67.2% |
$15.1K - $22.8K
|
39.9K
$106K
|
|
|
Jul 14, 2025
Q2 2025
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
1.78K+ 16.17% |
$1.68K - $2.53K
|
12.8K
$34.1K
|
|
|
Aug 07, 2025
Q2 2025
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
7+ 6.73% |
$6.58 - $9.94
|
111
$295
|
|
|
Aug 12, 2025
Q2 2025
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2025
Q2 2025
|
Ubs Group Ag
|
SELL
|
- |
-486- 55.04% |
$457 - $690
|
397
$1.06K
|
|
|
Aug 14, 2025
Q2 2025
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-162K- 18.03% |
$153K - $231K
|
738K
$1.96M
|
|
|
Aug 14, 2025
Q2 2025
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-800K- 45.96% |
$752K - $1.14M
|
941K
$2.5M
|
|